Long-term effects of preeclampsia on the maternal cardiovascular system

doi:10.3877/cma.j.issn.2095-3259.2025.04.003

Abstract

Abstract:

Preeclampsia is a common pregnancy-specific disease in China. With the deepening of research, clinicians have gradually realized that it is not only a major cause of adverse outcomes for both pregnant women and fetuses, but also an independent risk factor for long-term cardiovascular diseases in women. By inducing cardiac structural and functional changes, it primarily increases the risk of long-term cardiovascular diseases, including atherosclerosis, coronary artery disease, and heart failure. In future clinical practice, it is essential to establish a lifelong risk management system across specialties for women with a history of preeclampsia, and to conduct in-depth studies on genetic/epigenetic mechanisms to develop targeted preventive strategies, thereby reducing the burden of long-term cardiovascular diseases.

Key words: Preeclampsia, Cardiovascular diseases, Long-term impact

Manling Luo, Liping Huang. Long-term effects of preeclampsia on the maternal cardiovascular system[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2025, 14(04): 205-209.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2025.04.003

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2025/V14/I04/205

References 45

[1]	Yang Y, Ray IL, Zhu J, et al. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China[J]. JAMA Netw Open，2021，4(5)：e218401.
[2]	Poon LC, Nguyen-Hoang L, Smith GN, et al. Hypertensive disorders of pregnancy and long-term cardiovascular health: FIGO best practice advice[J]. Int J Gynaecol Obstet，2023，160 Suppl 1：22-34.
[3]	Melchiorre K, Sharma R, Khalil A, et al. Maternal cardiovascular function in normal pregnancy: evidence of maladaptation to chronic volume overload[J]. Hypertension，2016，67(4)：754-762.
[4]	陈敦金，杜培丽. 子痫前期的心肺损伤[J/CD]. 中华产科急救电子杂志，2013，2(3): 182-185.
[5]	Shaw LJ, Patel K, Lala-Trindade A, et al. Pathophysiology of preeclampsia-induced vascular dysfunction and implications for subclinical myocardial damage and heart failure[J]. JACC Adv，2024，3(6)：100980.
[6]	蔚欣，王雁玲. 子痫前期的基础研究进展[J/OL]. 中华产科急救电子杂志，2021，10(3): 129-132.
[7]	Schwartz KS, Sun M, Jalal DI, et al. Reduced AT2R signaling contributes to endothelial dysfunction after preeclampsia[J]. Hypertension，2025，82(5)：904-913.
[8]	Murugesan S, Addis DR, Hussey H, et al. Decreased extracellular vesicle vasorin in severe preeclampsia plasma mediates endothelial dysfunction[J]. J Am Heart Assoc，2025，14(7)：e037242.
[9]	Valentini A, Heilmann RM, Kühne A, et al. The Renin-angiotensin-aldosterone System (RAAS): beyond cardiovascular regulation[J]. Vet Sci，2025，12(8)：777.
[10]	Birukov A, Wiesemann S, Golic M, et al. Myocardial evaluation of post-preeclamptic women by CMR: is early risk stratification possible？[J]. JACC Cardiovasc Imaging，2020，13(5)：1291-1293.
[11]	Brown MC, Best KE, Pearce MS, et al. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis[J]. Eur J Epidemiol，2013，28(1)：1-19.
[12]	Orabona R, Sciatti E, Vizzardi E, et al. Elastic properties of ascending aorta in women with previous pregnancy complicated by early- or late-onset pre-eclampsia[J]. Ultrasound Obstet Gynecol，2016，47(3)：316-323.
[13]	Lan L, Zhang C, Geng J, et al. Echocardiographic assessment of the maternal heart: a review of the structural and functional changes during pregnancy[J]. Echocardiography，2025，42(6)：e70220.
[14]	Vaught AJ, Kovell LC, Szymanski LM, et al. Acute cardiac effects of severe pre-eclampsia[J]. J Am Coll Cardiol，2018，72(1)：1-11.
[15]	Popescu MR, Bouariu A, Ciobanu AM, et al. Pregnancy complications lead to subclinical maternal heart dysfunction-the importance and benefits of follow-up using speckle tracking echocardiography[J]. Medicina (Kaunas)，2022，58(2)：296.
[16]	Dall′Asta A, D′Antonio F, Saccone G, et al. Cardiovascular events following pregnancy complicated by pre-eclampsia with emphasis on comparison between early- and late-onset forms: systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol，2021，57(5)：698-709.
[17]	Johnson MP, Brennecke SP, East CE, et al. Genetic dissection of the pre-eclampsia susceptibility locus on chromosome 2q22 reveals shared novel risk factors for cardiovascular disease[J]. Mol Hum Reprod，2013，19(7)：423-437.
[18]	Small HY, Akehurst C, Sharafetdinova L, et al. HLA gene expression is altered in whole blood and placenta from women who later developed preeclampsia[J]. Physiol Genomics，2017，49(3)：193-200.
[19]	Hromadnikova I, Kotlabova K, Dvorakova L, et al. Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications[J]. Int J Cardiol，2019，291：158-167.
[20]	Murphy MS, Casselman RC, Tayade C, et al. Differential expression of plasma microRNA in preeclamptic patients at delivery and 1 year postpartum[J]. Am J Obstet Gynecol，2015，213(3)：367.e1-367.e9.
[21]	Cirkovic A, Stanisavljevic D, Milin-Lazovic J, et al. Preeclamptic women have disrupted placental microRNA expression at the time of preeclampsia diagnosis: meta-analysis[J]. Front Bioeng Biotechnol，2021，9：782845.
[22]	Mousa AA, Archer KJ, Cappello R, et al. DNA methylation is altered in maternal blood vessels of women with preeclampsia[J]. Reprod Sci，2012，19(12)：1332-1342.
[23]	Pfaller B, Siu SC, D′Souza R, et al. Impact of obesity on outcomes of pregnancy in women with heart disease[J]. J Am Coll Cardiol，2021，77(10)：1317-1326.
[24]	Ghossein-Doha C, van Neer J, Wissink B, et al. Pre-eclampsia: an important risk factor for asymptomatic heart failure[J]. Ultrasound Obstet Gynecol，2017，49(1)：143-149.
[25]	Honigberg MC, Zekavat SM, Aragam K, et al. Long-term cardiovascular risk in women with hypertension during pregnancy[J]. J Am Coll Cardiol，2019，74(22)：2743-2754.
[26]	Hansen AL, Søndergaard MM, Hlatky MA, et al. Adverse pregnancy outcomes and incident heart failure in the Women′s Health Initiative[J]. JAMA Netw Open，2021，4(12)：e2138071.
[27]	Williams D, Stout MJ, Rosenbloom JI, et al. Preeclampsia predicts risk of hospitalization for heart failure with preserved ejection fraction[J]. J Am Coll Cardiol，2021，78(23)：2281-2290.
[28]	Gevaert AB, Boen JRA, Segers VF, et al. Heart failure with preserved ejection fraction: a review of cardiac and noncardiac pathophysiology[J]. Front Physiol，2019，10：638.
[29]	Clemmensen TS, Christensen M, Kronborg CJS, et al. Long-term follow-up of women with early onset pre-eclampsia shows subclinical impairment of the left ventricular function by two-dimensional speckle tracking echocardiography[J]. Pregnancy Hypertens，2018，14：9-14.
[30]	Nagueh SF. Left ventricular diastolic function: understanding pathophysiology, diagnosis, and prognosis with echocardiography[J]. JACC Cardiovasc Imaging，2020，13(1 Pt 2)：228-244.
[31]	Palmiero P, Caretto P, Zito A, et al. Left ventricular diastolic function in atrial fibrillation: methodological implications and clinical considerations[J]. Echocardiography，2024，41(4)：e15818.
[32]	Uzan J, Carbonnel M, Piconne O, et al. Pre-eclampsia: pathophysiology, diagnosis, and management[J]. Vasc Health Risk Manag，2011，7：467-474.
[33]	Buono MGD, Montone RA, Camilli M, et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC State-of-the-Art Review[J]. J Am Coll Cardiol，2021，78(13)：1352-1371.
[34]	Hauge MG, Damm P, Kofoed KF, et al. Early coronary atherosclerosis in women with previous preeclampsia[J]. J Am Coll Cardiol，2022，79(23)：2310-2321.
[35]	American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: ACOG practice bulletin summary, Number 222[J]. Obstet Gynecol，2020，135(6)：1492-1495.
[36]	Inversetti A, Pivato CA, Cristodoro M, et al. Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis[J]. Eur Heart J Qual Care Clin Outcomes，2024，10(1)：4-13.
[37]	Honigberg MC, Jowell AR. Accelerated coronary atherosclerosis after preeclampsia: seeing is believing[J]. J Am Coll Cardiol，2022，79(23)：2322-2324.
[38]	Honigberg MC, Economy KE, Pabón MA, et al. Coronary microvascular function following severe preeclampsia[J]. Hypertension，2024，81(6)：1272-1284.
[39]	Voskamp LW, Rousian M, Koerts JJ, et al. Risk factors for chronic hypertension 5 years after a pregnancy complicated by preeclampsia: a systematic review and meta-analysis[J]. J Hypertens，2025，43(6)：939-948.
[40]	Battarbee AN, Sinkey RG, Harper LM, et al. Chronic hypertension in pregnancy[J]. Am J Obstet Gynecol，2020，222(6)：532-541.
[41]	Opichka MA, Rappelt MW, Gutterman DD, et al. Vascular dysfunction in preeclampsia[J]. Cells，2021，10(11)：3055.
[42]	Kivelä A, Heinonen S, Kivinen K, et al. Hypertensive pregnancy complications and maternal characteristics as predictors of cardiovascular health within ten years after delivery[J]. Pregnancy Hypertens，2023，34：5-12.
[43]	Duvekot JJ. Do all women after hypertensive diseases of pregnancy have the same long-term risk of cardiovascular disease in later life？[J]. Best Pract Res Clin Obstet Gynaecol，2025，100：102597.
[44]	Borges VTM, Zanati SG, Peraçoli MTS, et al. Maternal left ventricular hypertrophy and diastolic dysfunction and brain natriuretic peptide concentration in early- and late-onset pre-eclampsia[J]. Ultrasound Obstet Gynecol，2018，51(4)：519-523.
[45]	Yang C, Baker PN, Granger JP, et al. Long-term impacts of preeclampsia on the cardiovascular system of mother and offspring[J]. Hypertension，2023，80(9)：1821-1833.

Please choose a citation manager

Content to export